Lasmed LLC works in the fields of laser medicine and pain research, particularly in the development of protocols, tools and pain models for drug discovery, preclinical trials and clinical research. The company's protocols allow differential and quantitative activation of C and A in vivo and in vitro pain models as well as quantitative testing of heat sensitive DRG and TRPV expressed HEK cells. This is achieved via a diode laser selective stimulator, which can selectively assess function of small C- or A-delta fibers in acute inflammatory and/or chronic pain states.
